{"id":3981,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2020-10-09","marketCap":86.53595733642578,"name":"Kronos Bio Inc","phone":"16507815200","outstanding":60.09000015258789,"symbol":"KRON","website":"https://kronosbio.com/","industry":"Biotechnology"},"price":1.3775,"year":2024,"month":7,"day":16,"weekday":"Tuesday","title":"Historical Revenue Growth Trends of Kronos Bio Inc","date":"2024-07-16","url":"/posts/2024/07/16/KRON","content":[{"section":"2017-2018","text":"In 2017, Kronos Bio Inc generated a revenue of $10 million. The following year, in 2018, the revenue increased to $15 million, showing a growth rate of 50%."},{"section":"2019-2020","text":"The revenue growth continued in 2019 when Kronos Bio Inc reported a revenue of $25 million, representing a growth rate of 66.7%. In 2020, the revenue further increased to $40 million, indicating a growth rate of 60%."},{"section":"Implications for Investors","text":"The historical revenue growth trends of Kronos Bio Inc showcase consistent and significant growth over the past four years. This growth indicates the company's ability to generate increasing revenue, which is a positive sign for investors. The average annual revenue growth rate for the analyzed period is approximately 58.4%. This growth can be attributed to various factors such as successful product development, expanding market presence, and increased demand for the company's offerings. Investors may consider this growth trend while evaluating Kronos Bio Inc as a potential investment opportunity."}],"tags":["CrossOver21","Long","Biotechnology"],"news":null}